# Dongyoul Choi

> Dongyoul Choi is a Series A investor at Stonebridge Capital backing FinTech and Finance. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Stonebridge Capital](https://shizune.co/investors/profile/stonebridge-capital)
- Total investments: 5
- Last investment: Jul 2024
- Lead investor: 60%
- Last updated: Aug 2026

Dongyoul Choi is a Series A investor at Stonebridge Capital focused on FinTech and Finance. Dongyoul Choi - Managing Director @ Stonebridge Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| FinTech | 1 | 20% |
| Finance | 1 | 20% |
| Payments | 1 | 20% |
| Health Care | 1 | 20% |
| Biotechnology | 1 | 20% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Series B | 1 | 20% |
| Funding Round | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 2 | 40% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| JLT | JLT supplies industrial automation equipment solutions and focuses on technology improvement through an integrated welding solution development project. | $3.7M | Series A | Jul 08, 2024 |  |
| TAU-PNU MEDICAL | TAU is developing state-of-the-art minimally invasive catheter-based surgical methodologies for treating structural heart diseases like Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia. | $22M | Series B | Jul 09, 2020 |  |
| TAU-PNU MEDICAL | TAU is developing state-of-the-art minimally invasive catheter-based surgical methodologies for treating structural heart diseases like Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia. | $2.7M |  | Feb 21, 2019 |  |
| TAU-PNU MEDICAL | TAU is developing state-of-the-art minimally invasive catheter-based surgical methodologies for treating structural heart diseases like Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia. | $4.5M | Series A | Mar 13, 2017 |  |
| SentBe | Sentbe is creating finance without borders. As a fintech money transfer service, Sentbe provides an easier, faster, and more convenient way to transfer money abroad. | $1.4M | Series A | Oct 11, 2016 |  |

5 of 5 investments shown.

## Co-investors
- [BUSAN UNITED HOLDINGS](https://shizune.co/investors/profile/busan-united-holdings) — VC Fund, 1 deal together
- [East Gate Partners](https://shizune.co/investors/profile/east-gate-partners-5c3d) — VC Fund, 1 deal together
- [Korea Technology Finance Corporation](https://shizune.co/investors/profile/korea-technology-finance-corporation) — VC Fund, 1 deal together
- [L&S Venture Capital](https://shizune.co/investors/profile/l-s-venture-capital) — VC Fund, 1 deal together
- [Smilegate Investment](https://shizune.co/investors/profile/smilegate-investment) — VC Fund, 1 deal together
- [STIC Ventures](https://shizune.co/investors/profile/stic-ventures) — VC Fund, 1 deal together

## About Stonebridge Capital

VC Fund · Seoul, South Korea

Stonebridge Capital is a venture capital and private equity fund management firm that specializes in alternative investments. Stonebridge Capital experts have established and managed a total of ten funds, each of which has produced consistent investment performance, which is only possible due to the management's industry expertise and thoroughrisk control management.

5 contacts available at Stonebridge Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Dongyoul Choi | Managing Director | https://shizune.co/investors/profile/dongyoul-choi |
| Gil Young Oh | Compliance Officer | https://shizune.co/investors/profile/gil-young-oh |
| Hansu Lee | Manager | https://shizune.co/investors/profile/hansu-lee |
| Hyunae Kim | Manager | https://shizune.co/investors/profile/hyunae-kim |
| Jaeha Park | Manager | https://shizune.co/investors/profile/jaeha-park |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Dongyoul Choi invest in?

Dongyoul Choi invests primarily in FinTech, Finance and Payments startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dongyoul Choi last invest?

The most recent investment recorded for Dongyoul Choi closed in Jul 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co